Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
09/21/2005 | CN1219531C A medicine for treating bed-sore and method for preparing same |
09/21/2005 | CN1219526C Chinese medicine for bone-setting and method for preparing same |
09/21/2005 | CN1219525C Chinese medicine for treating women's ovary cancer and uterine myoma |
09/21/2005 | CN1219524C Medicine for treating femoral head necrosis and its preparation method |
09/21/2005 | CN1219521C A scar-removing acne-controlling formulation and preparation method |
09/21/2005 | CN1219516C Medical use of 11, 11'-dideoxy wotixilin |
09/20/2005 | US6946133 Prostate specific antigen oligo-epitope peptide |
09/20/2005 | US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis |
09/20/2005 | US6946127 Block exposure to nerve toxicity |
09/20/2005 | US6945247 Method of treating cardio pulmonary diseases with no group compounds |
09/20/2005 | CA2189882C Papillomavirus vaccines |
09/18/2005 | CA2461241A1 Chemical dissociation of cell aggregates |
09/15/2005 | WO2005085429A1 Reverse-flow perfusioin of three-dimensional scaffolds |
09/15/2005 | WO2005085424A2 Endothelial progenitor cells and methods of use thereof |
09/15/2005 | WO2005085423A1 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors |
09/15/2005 | WO2005085422A1 Adult stem cells and uses thereof |
09/15/2005 | WO2005085421A2 Treatment of spinal conditions |
09/15/2005 | WO2005085418A1 Novel lactic acid bacterium |
09/15/2005 | WO2005084725A1 Compositions for repairing bone and methods for preparing and using such compositions |
09/15/2005 | WO2005084691A1 Method of proliferating precursor cells |
09/15/2005 | WO2005084646A1 Powdered compositions of sensitive active materials in an at least partially amorphous state |
09/15/2005 | WO2005084463A1 Aggregates of eyeballs of crustaceans, usage, foods coataining the same, and production processes |
09/15/2005 | WO2005060709A3 Methods of use of probiotic bifidobacteria for companion animals |
09/15/2005 | WO2005052140A3 Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
09/15/2005 | WO2005047491A3 Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
09/15/2005 | WO2005047458A3 Modified recombinant vaccina viruses and other microorganisms, uses thereof |
09/15/2005 | WO2005039606A3 Moderating the effect of endotoxins |
09/15/2005 | WO2005038012A3 Cartilage and bone repair and regeneration using postpartum-derived cells |
09/15/2005 | WO2005009450A3 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles |
09/15/2005 | WO2004110372A3 Room temperature storage of organs |
09/15/2005 | WO2004050832A3 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens |
09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
09/15/2005 | US20050204406 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins |
09/15/2005 | US20050203057 Treatment of cancers |
09/15/2005 | US20050203008 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
09/15/2005 | US20050202428 Notch signaling inhibitory RNA sequences for use in treatment and prevention of cell proliferative and developmental disorders |
09/15/2005 | US20050202148 Preparation of microbial oil |
09/15/2005 | US20050202098 Administering leukocytes to suppress immune response; autoimmune diseases; graft versus host disease |
09/15/2005 | US20050202097 Lubricant for the ocular surface |
09/15/2005 | US20050202064 Administering an uronic acid or uronic acid derivative, a saccharide; anticarcinogenic |
09/15/2005 | US20050202058 Cell-seeded extracellular matrix grafts |
09/15/2005 | US20050201997 Dioxin elimination promoter |
09/15/2005 | US20050201996 Administering a probiotic to a household pet; contact dermatitis, actinic dermatitis, dermatitis caused by microbial infection, eczema and rosacea |
09/15/2005 | US20050201992 Culture with human dendritic cells wherein the hybrid cells were generated by fusing tumor cells dissociated from a tumor by mechanical dissociation with a highly enriched population of human B-cells; avoiding the problems of immune suppression, autoimmune reactions, and self-recognition; kits; antitumor |
09/15/2005 | US20050201990 Endothelial progenitor cells and methods of use thereof |
09/15/2005 | US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases) |
09/15/2005 | US20050201952 Treatment and prevention of viral hepatitis infections |
09/15/2005 | DE102004037184B3 Tissue transplant construct, useful especially for correcting defects in the bladder, comprises collagen-containing membrane supporting layers of organ-specific cells, with the outermost layer fully differentiated |
09/15/2005 | CA2599823A1 Reverse-flow perfusion of three-dimensional scaffolds |
09/15/2005 | CA2559110A1 Endothelial progenitor cells and methods of use thereof |
09/15/2005 | CA2558436A1 Method of proliferating precursor cells |
09/15/2005 | CA2558200A1 Compositions for repairing bone and methods for preparing and using such compositions |
09/15/2005 | CA2558056A1 Treatment of spinal conditions |
09/15/2005 | CA2557876A1 Powdered compositions of sensitive active materials in an at least partially amorphous state |
09/15/2005 | CA2530514A1 Cell therapy formulation method and composition |
09/15/2005 | CA2500926A1 Tumor/b-cell hybrid cells and uses thereof |
09/14/2005 | EP1574578A1 Monomeric protein of the TGF-beta family |
09/14/2005 | EP1574577A2 Growth differentiation factor-11 |
09/14/2005 | EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
09/14/2005 | EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
09/14/2005 | EP1572989A1 Gen 2.2 dendritic cell line |
09/14/2005 | EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof |
09/14/2005 | EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
09/14/2005 | EP1572885A2 Methods for treating diabetes and other blood sugar disorders |
09/14/2005 | EP1572879A2 Method of producing region-specific neurons from human neuronal stem cells |
09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
09/14/2005 | EP1572168A2 Anti-infarction molecules |
09/14/2005 | EP1572108A2 Functional mutations in respiratory syncytial virus |
09/14/2005 | EP1572089A2 Method for growing human organs, treating diseases, and increasing longevity |
09/14/2005 | EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells |
09/14/2005 | EP1572069A2 Protective factors against inflammation, burns and noxious stimuli |
09/14/2005 | EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
09/14/2005 | EP1571910A2 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
09/14/2005 | EP1390062A4 Modulators of elastase inhibitor secretion |
09/14/2005 | EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants. |
09/14/2005 | EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer |
09/14/2005 | EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors |
09/14/2005 | EP1030676B1 Bonding of cartilaginous matrices using isolated chondrocytes |
09/14/2005 | CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
09/14/2005 | CN1668746A MUC-1 antigen with reduced number of VNTR repeat units |
09/14/2005 | CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
09/14/2005 | CN1668732A Treatments with autologous fibroblast |
09/14/2005 | CN1668728A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
09/14/2005 | CN1668631A Fractionation of phytosterol esters in oil |
09/14/2005 | CN1668327A Transdermal botulinum toxin compositions |
09/14/2005 | CN1668324A Methods, compositions, and growth and differentiation factors for insulin-producing cells |
09/14/2005 | CN1668319A Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid |
09/14/2005 | CN1668318A Avian appeasing pheromones to decrease stress, anxiety and aggressiveness |
09/14/2005 | CN1668317A Pharmceutical composition for treatment of wounds conntaining blood plasma or serum |
09/14/2005 | CN1668211A Method for improving immune function in mammals using lactobacillus reuteri strains |
09/14/2005 | CN1667119A Adult stem cell and its culturing method and use |
09/14/2005 | CN1666822A Apparatus for the continuous separation of biological fluids into components and method of using same |
09/14/2005 | CN1666778A Anti-oxidation, anti-senium oyster product and its preparation method |
09/14/2005 | CN1666777A Medicinal preparation of brain protolysate for injection and preparation method thereof |
09/14/2005 | CN1666673A 珍珠饮品原料及其制备方法 Pearl Drinks materials and preparation method |
09/14/2005 | CN1666659A Health food for protecting and improving vision |
09/14/2005 | CN1666654A Preparation method of common house-fly grub freeze-drying nutritious powder |
09/14/2005 | CN1218983C Folic acid-polydiol compound and its medicinal composition |
09/14/2005 | CN1218744C Preparing method of burn and scald treating medicine |
09/14/2005 | CN1218738C Proprietary Chinese internal medicine for promoting blood circulation to stop pain |